Hyman, David M <br/><br/>
Predictors of early treatment discontinuation in patients enrolled on Phase I oncology trials.  [electronic resource] 

 -  Oncotarget  Aug 2015 
 - 19316-27 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.2909  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Clinical Trials, Phase I as Topic--methods<br/>Cohort Studies<br/>Dose-Response Relationship, Drug<br/>Female<br/>Humans<br/>Male<br/>Maximum Tolerated Dose<br/>Middle Aged<br/>Patient Selection<br/>Risk Factors<br/>Young Adult